Gremubamab
Gremubamab Uses, Dosage, Side Effects, Food Interaction and all others data.
Gremubamab is under investigation in clinical trial NCT02255760 (Phase 1 Randomized Double-blind Placebo Controlled Study to Evaluate Safety and PK of MEDI3902 in Healthy Adults).
| Trade Name | Gremubamab |
| Generic | Gremubamab |
| Gremubamab Other Names | Gremubamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Gremubamab
